Tirzepatide Plus represents a new class of medicines studied for the treatment of obesity and diabetes type II. Tirzepatide (branded under Mounjaro) and its counterpart Semaglutide (branded under Ozempic & Wegovy) have become the premier class of medications for the treatment and management of weight loss.

• Weight Reduction

• Improved cholesterol levels

• Reduction of fat mass 3 times greater than lean mass leading to improved body composition

• Decreased waist circumference

• Improved blood pressure

**********************************************************The Tirzepatide you will be prescribed and receive is a generic compounded medication. It is NOT associated with Elli Lilly company nor the brand-name medication Mounjaro®.

*******************************************************************

Absolutely. Here are the facts:

A body-weight reduction of 5% has been considered the threshold for meaningful effect on the improvement of metabolic health.  For perspective: the average weight reduction with older weight loss medications is about 3 to 8.6%.  

In most recent studies, patients on the lowest dose of tirzepatide (5mg) had a weight reduction of 11.9% with 30% of participants reaching weight-loss of 20% or more.  Higher doses of tirzepatide have shown weight reduction upwards of 25% or more!

Daily subcutaneous (SQ) injection which can be self-administered in thigh area or deltoid muscle.

• 2mL vial of Tirzepatide/B12

• Syringes/needles

• Alcohol pads

• Telehealth consultation with a physician

All home kits require a prescription and must be approved by one of our physicians.

Simply add to your cart and fill out the required medical information on check. One of our physicians will contact you shortly thereafter for a Telehealth visit to discuss your kit, your medical history, and fulfill the prescription request once approved.